DuChemBio
Manufacturing · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Wausan-ro Mapo-gu Seobong Gallery 81, Se...Phone Number
+82 23324868Website
www.duchembio.comRevenue
$15.9 MillionStock Symbol
176750Industry
About DuChemBio
Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET imaging tracers in South Korea. As a pioneer of a fully integrated nuclear diagnostics business model, DCB develops, manufactures, and commercializes radiopharmaceutical tracers for PET/CT and PET/MRI hybrid imaging. The company operates 7 radio-pharmacy facilities across the country, is closely collaborating with leading hospitals and research centers in Seoul to develop and advance the field of nuclear medicine in South Korea. DCB has successfully launched novel proprietary radiopharmaceutical products both developed locally and licensed from international partners. DuChemBio has been advised by BGM Associates GmbH, a Berlin-based strategy and transactions advisory firm focused on healthcare and life science industries.Explore more
SIC Code 28,283NAICS Code 32,325Ticker KRX: 176750Show moreDuChemBio Org Chart
DuChemBio Tech Stack
A closer look at the technologies used by DuChemBio
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DuChemBio
Sign Up For FreeTo access detailed company insights
Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET imaging tracers in South Korea. As a pioneer of a fully integrated nuclear diagnostics business model, DCB develops, manufactures, and commercializes radiopharmaceutical tracers for PET/CT and PET/MRI hybrid im... Read More